(Stroke. 2000;31:2641.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Division of Neurology, Department of Medicine and Therapeutics (K.S.W., H.L., A.W., R.K.), and the Department of Diagnostic Radiology and Organ Imaging (Y.L.C., A.A., W.W.W.L.), the Chinese University of Hong Kong, Shatin, Hong Kong, SAR.
Correspondence to Dr Ka Sing Wong, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR. E-mail ks-wong{at}cuhk.edu.hk
| Abstract |
|---|
|
|
|---|
MethodsOn the basis of transcranial Doppler of the intracranial arteries with supplementary duplex ultrasound of the carotid arteries, we determined the number of occlusive arteries in the craniocervical circulation of consecutive patients who were hospitalized for acute cerebral ischemia. Patients were followed for 6 months for further vascular events (including transient ischemic attack, stroke, and acute coronary syndrome) or death.
ResultsAmong 705 consecutive Chinese patients studied, occlusive arteries were found in 345 patients (49%): 258 patients (37%) had intracranial lesions only, 71 (10%) had both extracranial and intracranial lesions, and 16 (2.3%) had extracranial lesions only. Sixty-three (18%) of the 345 patients with occlusive arteries and 35 (9.7%) of the 360 patients without occlusive arteries had further vascular event or death within 6 months. The risk of vascular events or death increased rapidly with rising numbers of occlusive arteries, after adjustment for vascular risk factors and stroke severity (adjusted odds ratio [OR] 1.25 per occlusive artery, 95% CI 1.12 to 1.39). Other independent risk factors included age (OR 1.03 per year of age, 95% CI 1.01 to 1.05) and atrial fibrillation (OR 3.00, 95% CI 1.40 to 6.69).
ConclusionsIn patients with predominantly intracranial large-artery occlusive disease, the presence and the total number of occlusive arteries in the craniocervical circulation predict further vascular events or death within 6 months after stroke. Transcranial Doppler ultrasound is an important investigation for the evaluation of patients with stroke in populations at risk of intracranial atherosclerotic disease.
Key Words: arterial occlusive diseases cerebral ischemia Chinese prognosis ultrasonography, Doppler, transcranial
| Introduction |
|---|
|
|
|---|
The diagnosis of intracranial arterial stenosis or occlusion requires vascular imaging of the craniocervical circulation. For decades, conventional contrast angiography has been the only method to visualize the intracranial circulation in clinical practice. The invasive nature of conventional angiography and the risk of perioperative complications7 hinder its widespread use in the study of intracranial vascular lesions in stroke patients. Consequently, there has been no large prospective study to assess the clinical significance of the presence of intracranial occlusive disease. The advent of technologies such as transcranial Doppler ultrasound permits studying large numbers of patients safely and reliably in clinical practice.8 9 In the present prospective longitudinal study of consecutive hospitalized patients with cerebral ischemia, we investigate whether the presence and extent of occlusive arteries in the craniocervical circulation predict outcome in terms of further vascular event or death.
| Subjects and Methods |
|---|
|
|
|---|
Ultrasound Examination
All enrolled patients were examined by transcranial
Doppler (EME TC-2000). We studied the intracranial large arteries
through the temporal, occipital, and orbital windows by use of a
standardized protocol based on a principle previously
described.10 Briefly, we examined the following arteries
with 4-cm increments: middle cerebral artery (MCA) (temporal window, 52
to 64 mm), anterior cerebral artery (temporal window, 68 to
72 mm), posterior cerebral artery (temporal window, 56 to 64
mm), siphon internal carotid artery (orbital window, 60 to
68 mm), and vertebrobasilar artery (occipital window, 56 to
106 mm). The locations of the 11 studied arterial
segments are illustrated in Figure 1
. We
regarded the vertebral arteries and the basilar artery as one segment
because of the technical difficulty in separating the vertebral
arteries from the basilar artery by transcranial
Doppler. For a similar reason, we categorized vascular lesions in
the terminal internal carotid artery just before the bifurcation as
lesions in the MCA. The extracranial carotid arteries were examined by
a 4-MHz transducer. In addition, a duplex color Doppler examination
of the carotid arteries was also performed. Patients were classified as
having occlusive disease if at least one of the studied arteries showed
evidence of stenosis or occlusion. The criteria for occlusive
arteries were defined by the peak systolic flow velocity as
follows:
140 cm/s for the MCA,
120 cm/s for the anterior cerebral
artery,
100 cm/s for the posterior cerebral artery and
vertebrobasilar artery, and
120 cm/s for the siphon internal carotid
artery and extracranial carotid artery. Apart from the above velocity
criteria, we took into account the age of patients, presence of
turbulence or musical sound, and whether the abnormal velocity was
segmental. We diagnosed occlusion of the MCA if all basal arteries
except the MCA in question were detectable or if the asymmetry index of
the symptomatic MCA was <-21% compared with the
contralateral MCA.11 Cerebral arteries that could not be
insonated because of poor temporal acoustic windows were regarded as
nonocclusive.
|
For classification of MCA stenosis, we defined mild stenosis as systolic peak velocity 140 to 209 cm/s, moderate stenosis as 210 to 280 cm/s, and severe stenosis as >280 cm/s.12 Assessment of the severity of stenosis in other intracranial vessels was not performed because of the lack of published or validated reports. For the duplex ultrasound examination of the extracranial carotid arteries, we used a Philips SD800 ultrasound machine and a 7.5-MHz transducer. The diagnostic criteria for >70% stenosis of the internal carotid artery in our laboratory required a peak systolic velocity ratio of >2.4. The above diagnostic criteria in our neurovascular laboratory were based on our laboratory references, which had a quality assurance program with supplementary angiographic studies. At our laboratory, we performed >1200 transcranial Doppler examinations in a year.
Outcome Assessment
The clinical management of the patients during hospitalization
and after discharge from hospital was left to the attending physicians
who were not involved in the present study. Patients and/or their
relatives were interviewed, and the medical records were examined 6
months after the index stroke. The prespecified outcomes were the
occurrence of further vascular events (including TIA, stroke, or acute
coronary syndrome) or death. We defined TIA and stroke as acute
onset of neurological deficit presumably of vascular origin after
investigations to exclude other causes. Acute coronary syndrome
included myocardial infarction (acute onset of chest pain plus typical
ECG changes and/or raised serum creatine kinase level) and new-onset
angina (acute onset of chest pain plus positive exercise stress test or
>50% stenosis in one of the major coronary arteries
on angiography). Each event was reviewed by an investigator who was
unaware of the results of the ultrasound study. The use of
antiplatelet and anticoagulant agents was recorded at the
6-month follow-up or before death.
Statistical Analysis
For comparison between patients with and without vascular
lesion, a t test was used for continuous variables, such
as age and blood pressure. Cross tabulations by
2 test were used for comparing categorical
variables. To study the effect of the presence and the number of
occlusive arteries on outcome, logistic regression analysis
with all potential variables entered at the same time was used. In
this model, the number of occlusive arteries and age were regarded as
continuous variables. All analyses were performed with the
use of SPSS/Windows version 9.0 statistical software. Statistical
significance was set at P
0.05 by 2-sided
analyses.
| Results |
|---|
|
|
|---|
|
|
For the distribution of intracranial and extracranial lesions among
patients with occlusive arteries, 258 (75%) patients had intracranial
vascular lesions only, 71 (21%) patients had both intracranial and
extracranial lesions, and 16 (4.6%) had extracranial lesions only
(Table 3
). Among patients with vascular
lesions, the average number of occlusive arteries was 2.7, and the
maximum number was 9 (Table 4
). MCA (253
patients), vertebrobasilar artery (139 patients), and anterior cerebral
artery (124 patients) were the 3 most commonly involved vessels. Among
253 patients with occlusive disease in the MCA, 190 patients had
stenosis, and 63 patients had occlusion.
|
|
Patients with vascular lesions were significantly more at risk of
further vascular events or death within the 6-month period after
cerebral ischemia than were patients without occlusive arteries
despite the more frequent use of antithrombotic agents (89% versus
78%, respectively). The adjusted odds ratio for further events or
death in the presence of occlusive artery disease was 1.76 (95% CI
1.11 to 2.79, P=0.016) compared with the absence of
occlusive artery disease, after correction for sex, age, and other
vascular risk factors. The risk of further vascular events or death
rose rapidly with an increasing number of occlusive arteries. The
proportion of patients with an event or death increased from 12.5% for
1 occlusive artery to 50% in patients with 9 occlusive arteries
(P<0.001 by the test for trend). The relationship between
the number of occlusive arteries and the percentage of patients with
further vascular events or death is illustrated in Figure 2
. The increased risk remained highly
significant after adjustment for sex, age, diabetes, hypertension,
ischemic heart disease, atrial fibrillation, previous stroke or
TIA, blood pressure on admission, and National Institutes of Health
Stroke Scale by logistic regression analysis (OR 1.25 per
occlusive artery, 95% CI 1.12 to 1.39; P<0.001) (Table 5
). Other independent predictors for
vascular events or death were advancing age (OR 1.03 per year of age,
95% CI 1.00 to 1.05; P=0.019) and atrial fibrillation (OR
2.99, 95% CI 1.40 to 6.69; P=0.005).
|
|
The outcome of patients with occlusion and different severity of MCA
stenosis are summarized in Table 6
. The risk of further events or death is
related to the status of MCA, with MCA occlusion having the highest
risk (21.4%), MCA stenosis having medium risk (16.6%), and
normal MCA having the lowest risk (12.2%) (
2
test for trend, P=0.03) Only patients whose presenting
symptoms were attributable to the MCA stenosis or occlusion
were included in the group with MCA disease. A total of 12 further
ischemic strokes and 8 TIAs occurred within 6 months. Eight
ischemic strokes (67%) and 3 TIAs (37.5%) were considered
relevant to the previous MCA occlusive diseases.
|
| Discussion |
|---|
|
|
|---|
3%. Unfortunately, no control group was
available to assess the impact of MCA occlusive disease because of the
study design of this subgroup analysis. In our cohort, we were
able to compare the prognosis of patients with or without vascular
lesions. We found that the presence of vascular lesions, predominantly
intracranial lesions, significantly increased the risk of further
vascular events or death (OR 1.76).
The recurrent events rate (including TIA, stroke, and all-cause
mortality) of 18% within the first 6 months in patients with
large-artery occlusive disease appears high. However, if only TIA and
stroke are included, the recurrent rate is only 11.6% (Figure 2
). Moreover, recurrent events are known to be much more common
in patients with large-artery occlusive disease than in patients with
lacunar or cardioembolic stroke20 and more common in
nonwhite patients.21 In a recent report of a
population-based study by Petty et al,20 recurrent stroke
occurred in 18.5% of patients with large-artery occlusive disease at
30 days.
For assessment of the severity of arterial occlusive disease (such as carotid stenosis), degree of stenosis has been the mainstay index to identify patients with high risk of recurrent stroke.22 23 24 Another approach for assessing further vascular risk in an individual patient is to assess the total number of occlusive arteries. This approach is possible because many patients in our cohort had multiple arterial involvement. Therefore, it is feasible to use the number of occlusive arteries as a variable to predict outcome. Our data show that the risk of further vascular events or death rises rapidly with an increase in the number of arterial lesions, even after adjustment for sex, age, other vascular risk factors, and stroke severity. This approach to predict outcome is biologically plausible, reflecting quantitatively the burden of occlusive disease in the craniocervical circulation. This finding adds to the current approaches to study vascular lesions, which emphasize degree of stenosis and plaque morphology as predictors of outcome.22 23 24
Transcranial Doppler is a relatively recent advance in imaging that enables measurement of blood flow velocity in large intracranial arteries through temporal, occipital, and orbital portions of the skull.25 It is an established method to diagnose hemodynamically significant stenosis in major intracranial arteries.8 9 It is safe, inexpensive, and easily accessible. However, transcranial Doppler does not provide information regarding the pathological nature of the stenosis. In addition to atherosclerosis, vasospasm after subarachnoid hemorrhage, arteritis, and fibrosis may also lead to increase in blood flow velocity in the cerebral arteries. Although we did not study the pathology of the occlusive lesions, previous autopsy studies of occlusive lesions in cerebral arteries in Asians showed them to be primarily atherosclerotic.26 27 28 Moreover, most of our patients were elderly and had multiple vascular risk factors. Therefore, atherosclerosis is probably the most likely cause of stenosis in our patients.
Lack of a good temporal window for insonation of the cerebral arteries is another inadequacy of the use of transcranial Doppler ultrasound in clinical practice. In the present study, 25% of the patients had poor temporal windows. In this group of patients, some patients might have occlusive disease of the cerebral arteries, but they were inappropriately categorized as having no vascular lesion. Despite this misclassification, which should have weakened the predictive value of the ultrasound, our data clearly demonstrate the clinical importance of vascular studies to predict the course of cerebral ischemia. Recent advances in ultrasound technology, such as the use of contrast-enhancing agents, may remedy this weakness and provide more accurate categorization of patients in the future. In view of the value of transcranial Doppler in predicting outcome as shown in the present study, contrast agents should be used to find stenotic lesions in our population.
It may be difficult for transcranial Doppler to detect a stenosis at the M2 and distal M1 segments of MCA closer than a depth of 51 mm. Inclusion of these lesions may further increase the prevalence of stenosis in our studied population.
Elevated flow velocity of the Doppler signal is the hallmark of an
arterial stenosis. Besides the presence of
turbulent flow, the presence of increase in end-diastolic
velocity with very tight stenoses, flow diversion to
neighboring arteries, and decrease in flow velocity with extremely
tight narrowing are also valuable observations that may enhance our
knowledge of the hemodynamic of individual patient.
However, these changes are difficult to quantify in all patients and
may pose practical problems with statistical analysis.
Moreover, apart from assessment of the MCA, there are no published
criteria for grading stenosis of intracranial arteries, such as
the anterior cerebral and the posterior cerebral arteries and the
siphon section of the internal carotid artery. Therefore, we limited
our analysis to the severity of MCA stenosis. Even for
the MCA, the flow velocity during acute stroke may change rapidly, with
recanalization of emboli or resolving
thrombus.29 Nevertheless, we found a significant trend
toward a worse prognosis for patients with occlusion than for patients
with stenosis, who, in turn, had a worse prognosis than did
patients without stenosis (Table 6
.) The number of
events in each category of severity of stenosis was small;
thus, analysis of individual categories might be
inaccurate.
In many ischemic stroke series, survivors usually die from
coronary events rather than recurrent strokes.30
In our patients, there were 44 recurrent strokes and 8 acute
coronary syndromes that occurred in the 6 months after cerebral
ischemia; 9 patients died from recurrent strokes, and only 1
patient died from ischemic heart disease. This observation
mirrors the predominance of cerebrovascular disease over
coronary artery disease in our population. Stroke outnumbered
acute myocardial infarction by
5 to 1 in a previous study of Chinese
patients.31 Therefore, preventing another stroke should
become a priority in the management of patients with cerebral
ischemia in our population. In current practice,
antiplatelet agent is the mainstay of therapy for the prevention of
recurrent stroke. The use of antiplatelet agents had also been
found to be beneficial for Asians with cerebral
ischemia.32 33 However, despite widespread use
(89%) of antiplatelet agents or warfarin in our cohorts, the risk
of further vascular events remains unacceptably high, especially in
patients with multiple occlusive vessels. Our data call for further
study of additional strategies to alleviate the dismal prognosis of
patients with multiple occlusive arterial diseases.
| Acknowledgments |
|---|
Received April 19, 2000; revision received July 20, 2000; accepted July 20, 2000.
| References |
|---|
|
|
|---|
2.
Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D.
Racial differences in the distribution of anterior circulation
occlusive disease. Neurology. 1984;34:5459.
3.
Nishimaru K, McHenry LK, Toole JF. Cerebral
angiographic and clinical differences in carotid system transient
ischemic attacks between American Caucasian and Japanese
patients. Stroke. 1984;15:5659.
4.
Sacco RL, Kargman DE, Gu Q, Zamanillo MC.
Race-ethnicity and determinants of intracranial atherosclerotic
cerebral infarction: the Northern Manhattan Stroke Study.
Stroke. 1995;26:1420.
5.
Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B.
Race and sex differences in the distribution of cerebral
atherosclerosis. Stroke. 1996;27:19741980.
6.
Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R.
Intracranial stenosis in Chinese patients with acute stroke.
Neurology. 1998;50:812813.
7. Bendszus M, Koltzenburg M, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet. 1999;354:15941597.[Medline] [Order article via Infotrieve]
8. Babikian VL, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Bogdahn U, Caplan LR, Spencer MP, Tegeler C, Ringelstein EB, et al. Transcranial Doppler ultrasonography: year 2000 update. J Neuroimaging. 2000;10:101105.[Medline] [Order article via Infotrieve]
9. Markus H. Transcranial Doppler ultrasound. J Neurol Neurosurg Psychiatry.1999;67:135137.
10. Babikian VL, Wechsler LR. Transcranial Doppler Ultrasonography. St Louis, Mo: Mosby-Year Book Inc; 1993.
11.
Zanette EM, Fieschi C, Bozzao L, Roberti C, Toni D,
Argentino C, Lenzi GL. Comparison of cerebral angiography and
transcranial Doppler sonography in acute stroke.
Stroke. 1989;20:899903.
12. Röther J, Schwartz A, Wentz KU, Rautenberg W, Hennerici M. Middle cerebral artery stenoses: assessment by magnetic resonance angiography and transcranial Doppler ultrasound. Cerebrovasc Dis. 1994;4:273279.
13. Hinton RC, Mohr JP, Ackerman RH, Adair LB, Fisher CM. Symptomatic middle cerebral artery stenosis. Ann Neurol. 1979;5:152157.[Medline] [Order article via Infotrieve]
14.
Craig DR, Meguro K, Watridge C, Robertson JT, Barnett
HJ, Fox AJ. Intracranial internal carotid artery stenosis.
Stroke. 1982;13:825828.
15.
Marzewski DJ, Furlan AJ, St. Louis P, Little JR, Modic
MT, Williams G. Intracranial internal carotid artery stenosis:
long-term prognosis. Stroke. 1982;13:821824.
16.
Corston RN, Kendall BE, Marshall J. Prognosis in middle
cerebral artery stenosis. Stroke. 1984;15:237241.
17.
Caplan L, Babikian V, Helgason C, Hier DB, DeWitt D,
Patel D, Stein R. Occlusive disease of the middle cerebral artery.
Neurology. 1985;35:97582.
18.
Wechsler LR, Kistler JP, Davis KR, Kaminski MJ. The
prognosis of carotid siphon stenosis. Stroke. 1986;17:714718.
19.
Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC,
Taylor W. Atherosclerotic disease of the middle cerebral artery.
Stroke. 1986;17:111220.
20.
Petty GW, Brown RD, Whisnant JP, Sicks JD, OFallon
WM, Wiebers DO. Ischemic stroke subtypes: a population-based
study of functional outcome, survival and recurrence.
Stroke. 2000;31:10621068.
21. Sheinart KF, Tuhrim S, Horowitz DR, Weinberger J, Goldman M, Godbold JH. Stroke recurrence is more frequent in blacks and Hispanics. Neuroepidemiology. 1998;17:188198.[Medline] [Order article via Infotrieve]
22.
Rothwell PM, Gibson R, Warlow CP. Interrelation between
plaque surface morphology and degree of stenosis on carotid
stenosis on carotid angiograms and risk of ischemic
stroke in patients with symptomatic carotid
stenosis. Stroke. 2000;31:615621.
23. European Carotid Surgery Trialists Collaborator Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (7099%) and with mild (029%) carotid stenosis. Lancet. 1991;337:12351243.[Medline] [Order article via Infotrieve]
24.
Norris JW, Zhu CZ, Bornstein N, Chambers BR. Vascular
risks of asymptomatic carotid stenosis.
Stroke. 1991;22:14851490.
25. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769774.[Medline] [Order article via Infotrieve]
26.
Reed DM, Resch JA, Hayashi T, MacLean C, Yano K. A
prospective study of cerebral artery atherosclerosis.
Stroke. 1988;19:820825.
27.
Leung SY, Ng TH, Yuen ST, Lauder IJ, Ho FC. Pattern of
cerebral atherosclerosis in Hong Kong Chinese: severity
in intracranial and extracranial vessels. Stroke. 1993;24:779786.
28.
Ogata J, Masuda J, Yutani C, Yamaguchi T. Mechanism of
cerebral artery thrombosis: a histopathological analysis on
eight necropsy cases. J Neurol Neurosurg Psychiatry. 1994;57:1721.
29. Alexandrov AV, Bladin CF, Norris JW. Intracranial blood flow velocities in acute ischemic stroke. Stroke. 1994;25:13781383.[Abstract]
30.
Adams HPJ, Kassell NF, Mazuz H. The patient with
transient ischemic attacks: is this the time for a new
therapeutic approach? Stroke. 1984;15:3715.
31.
Shi L, Hart RG, Sherman DG, Tegeler CH. Stroke in the
Peoples Republic of China. Stroke. 1989;20:15811585.
32. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:16411649.[Medline] [Order article via Infotrieve]
33.
Wong KS, for the Asia Acute Stroke Advisory Panel. Risk
factors for early death in acute ischemic stroke and
intracerebral hemorrhage: a prospective
hospital-based study in Asia. Stroke. 1999;30:23262330.
This article has been cited by other articles:
![]() |
B. L. Man, Y. P. Fu, Y. Y. Chan, W. Lam, A. C. F. Hui, W. H. Leung, V. Mok, and K. S. Wong Lesion Patterns and Stroke Mechanisms in Concurrent Atherosclerosis of Intracranial and Extracranial Vessels Stroke, October 1, 2009; 40(10): 3211 - 3215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Han, T. W. Leung, W. W. Lam, Y. O. Soo, A. W. Alexandrov, V. Mok, Y.-F. V. Leung, R. Lo, and K. S. Wong Preliminary Findings of External Counterpulsation for Ischemic Stroke Patient With Large Artery Occlusive Disease Stroke, April 1, 2008; 39(4): 1340 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Sharma, G. Tsivgoulis, A. Y. Lao, M. D. Malkoff, and A. V. Alexandrov Noninvasive Detection of Diffuse Intracranial Disease Stroke, December 1, 2007; 38(12): 3175 - 3181. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. De Silva, F.-P. Woon, M.-P. Lee, C. P.L.H. Chen, H.-M. Chang, and M.-C. Wong South Asian Patients With Ischemic Stroke: Intracranial Large Arteries Are the Predominant Site of Disease Stroke, September 1, 2007; 38(9): 2592 - 2594. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Wong, Y. N. Huang, H. B. Yang, S. Gao, H. Li, J. Y. Liu, Y. Liu, and A. Tang A door-to-door survey of intracranial atherosclerosis in Liangbei County, China Neurology, June 5, 2007; 68(23): 2031 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Wong, P. W. Ng, A. Tang, R. Liu, V. Yeung, and B. Tomlinson Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients Neurology, June 5, 2007; 68(23): 2035 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazighi, R. Tanasescu, X. Ducrocq, E. Vicaut, S. Bracard, E. Houdart, and F. Woimant Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA Study Neurology, April 25, 2006; 66(8): 1187 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gao, K. S. Wong, T. Hansberg, W. W. M. Lam, D. W. Droste, and E. B. Ringelstein Microembolic Signal Predicts Recurrent Cerebral Ischemic Events in Acute Stroke Patients With Middle Cerebral Artery Stenosis Stroke, December 1, 2004; 35(12): 2832 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Arenillas, C. A. Molina, P. Chacon, A. Rovira, J. Montaner, P. Coscojuela, E. Sanchez, M. Quintana, and J. Alvarez-Sabin High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis Neurology, July 13, 2004; 63(1): 27 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Gundamraj and K. K. Lauer Diagnosis of Intracranial Arterial Stenosis Using Transcranial Doppler Flowmetry Anesth. Analg., June 1, 2004; 98(6): 1776 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, May 11, 2004; 62(9): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Thomas, J. W. Lin, W. W.M. Lam, B. Tomlinson, V. Yeung, J. C.N. Chan, R. Liu, and K. S. Wong Increasing Severity of Cardiovascular Risk Factors With Increasing Middle Cerebral Artery Stenotic Involvement in Type 2 Diabetic Chinese Patients With Asymptomatic Cerebrovascular Disease Diabetes Care, May 1, 2004; 27(5): 1121 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
V C T Mok, A Wong, W W M Lam, Y H Fan, W K Tang, T Kwok, A C F Hui, and K S Wong Cognitive impairment and functional outcome after stroke associated with small vessel disease J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Wong and H. Li Long-Term Mortality and Recurrent Stroke Risk Among Chinese Stroke Patients With Predominant Intracranial Atherosclerosis Stroke, October 1, 2003; 34(10): 2361 - 2366. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Arenillas, J. Alvarez-Sabin, C. A. Molina, P. Chacon, J. Montaner, A. Rovira, B. Ibarra, and M. Quintana C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease Stroke, October 1, 2003; 34(10): 2463 - 2468. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Wong, H. Li, W. W.M. Lam, Y. L. Chan, and R. Kay Progression of Middle Cerebral Artery Occlusive Disease and Its Relationship With Further Vascular Events After Stroke Stroke, February 1, 2002; 33(2): 532 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Arenillas, C. A. Molina, J. Montaner, S. Abilleira, M. A. Gonzalez-Sanchez;, and J. Alvarez-Sabin Progression and Clinical Recurrence of Symptomatic Middle Cerebral Artery Stenosis: A Long-Term Follow-Up Transcranial Doppler Ultrasound Study Stroke, December 1, 2001; 32(12): 2898 - 2904. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |